Home › Trial NCT01622556
Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
- Trial IDNCT01622556
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of Virginia
- Enrollment6
- Start date2012-01
- ConditionsHematologic Malignancies
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.